ArticleJMA journal2026
Oral Squamous Cell Carcinoma Incidence in Japan Based on National Cancer Registry Data 2016-2019.
Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: No comprehensive national profiles of oral squamous cell carcinoma (OSCC) have been established in Japan. We set out to describe the profiles of OSCC cases, including demographic characteristics, regional disparities, and survival time on a national basis, using a population-based dataset in Japan. Methods: Using the national cancer registry (NCR) of Japan, we aggregated data on cases of OSCC from 2016 to 2019 that were classified according to the diagnostic criteria specified in the Japanese oral cancer guidelines. We calculated annual, detailed site-specific distributions by sex and age-standardized incidence rates for each year. The standardized incidence ratios by prefecture were computed using 2016 to 2019 data. One-year overall survival was estimated using the Kaplan-Meier method. Univariate and multivariate analyses were conducted using the Cox proportional hazards model. Results: Between 2016 and 2019, data were obtained on 30,537 OSCC incidence cases. In the most recent year, 2019, 57.0% of patients were men, and the mean age was 70.3 years. Among the specific OSCC sites, the tongue was the most common, accounting for more than half the cases. Over half the cancers were localized at the time of diagnosis. The age-standardized incidence rate in 2019 was 5.12 per 100,000 population. The standardized incidence ratios of OSCC among different prefectures ranged from 0.77 (Gifu Prefecture) to 1.37 (Miyagi Prefecture). The one-year survival rate for all OSCC cases diagnosed between 2016 and 2019 was 83.5%. Cox proportional hazards model analysis, adjusted for all covariates, revealed that women had a significantly lower risk of death within one year than men (hazard ratio = 0.81, 95% confidence interval = 0.76-0.87). Conclusions: Our study provides an overview of OSCC epidemiology in Japan using the NCR population-based dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.